Katrina J. Church - 15 Feb 2026 Form 4 Insider Report for Bioventus Inc. (BVS)

Role
SVP & Chief Compliance Officer
Signature
/s/ Anthony D'Adamio, Attorney-in-Fact
Issuer symbol
BVS
Transactions as of
15 Feb 2026
Net transactions value
-$17,640
Form type
4
Filing time
18 Feb 2026, 18:29:29 UTC
Previous filing
15 Apr 2025
SEC
View on sec.gov

Reporting Owners (1)

Name Relationship Address Signature Signature date CIK
CHURCH KATRINA J SVP & Chief Compliance Officer 4721 EMPEROR BOULEVARD, SUITE 100, DURHAM /s/ Anthony D'Adamio, Attorney-in-Fact 18 Feb 2026 0001204391

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction BVS Class A Common Stock Options Exercise $0 +4,375 +7.9% $0.000000 59,932 15 Feb 2026 Direct
transaction BVS Class A Common Stock Tax liability $17,640 -2,133 -3.6% $8.27 57,799 15 Feb 2026 Direct

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction BVS Restricted Stock Units Options Exercise $0 -4,375 -33% $0.000000 8,750 15 Feb 2026 Class A Common Stock 4,375 Direct F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Class A common stock.
F2 The RSU vest in four equal installments on each of the first four anniversaries of February 15, 2024, in each case subject to the Reporting Person continuing in service through the applicable vesting date.